282 related articles for article (PubMed ID: 22222710)
1. Muscarinic receptor agonists and antagonists: effects on cancer.
Spindel ER
Handb Exp Pharmacol; 2012; (208):451-68. PubMed ID: 22222710
[TBL] [Abstract][Full Text] [Related]
2. Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function.
Eglen RM
Auton Autacoid Pharmacol; 2006 Jul; 26(3):219-33. PubMed ID: 16879488
[TBL] [Abstract][Full Text] [Related]
3. Muscarinic receptor agonists and antagonists: effects on inflammation and immunity.
Verbout NG; Jacoby DB
Handb Exp Pharmacol; 2012; (208):403-27. PubMed ID: 22222708
[TBL] [Abstract][Full Text] [Related]
4. Human colon cancer cell proliferation mediated by the M3 muscarinic cholinergic receptor.
Frucht H; Jensen RT; Dexter D; Yang WL; Xiao Y
Clin Cancer Res; 1999 Sep; 5(9):2532-9. PubMed ID: 10499630
[TBL] [Abstract][Full Text] [Related]
5. Muscarinic agonists and antagonists: effects on the urinary bladder.
Sellers DJ; Chess-Williams R
Handb Exp Pharmacol; 2012; (208):375-400. PubMed ID: 22222707
[TBL] [Abstract][Full Text] [Related]
6. Blocking M2 muscarinic receptor signaling inhibits tumor growth and reverses epithelial-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC).
Zhao Q; Gu X; Zhang C; Lu Q; Chen H; Xu L
Cancer Biol Ther; 2015; 16(4):634-43. PubMed ID: 25778781
[TBL] [Abstract][Full Text] [Related]
7. Muscarinic receptor agonists and antagonists: effects on keratinocyte functions.
Grando SA
Handb Exp Pharmacol; 2012; (208):429-50. PubMed ID: 22222709
[TBL] [Abstract][Full Text] [Related]
8. Muscarinic receptors and ligands in cancer.
Shah N; Khurana S; Cheng K; Raufman JP
Am J Physiol Cell Physiol; 2009 Feb; 296(2):C221-32. PubMed ID: 19036940
[TBL] [Abstract][Full Text] [Related]
9. M3 muscarinic receptor antagonists inhibit small cell lung carcinoma growth and mitogen-activated protein kinase phosphorylation induced by acetylcholine secretion.
Song P; Sekhon HS; Lu A; Arredondo J; Sauer D; Gravett C; Mark GP; Grando SA; Spindel ER
Cancer Res; 2007 Apr; 67(8):3936-44. PubMed ID: 17440109
[TBL] [Abstract][Full Text] [Related]
10. Muscarinic receptor agonists and antagonists: effects on ocular function.
Mitchelson F
Handb Exp Pharmacol; 2012; (208):263-98. PubMed ID: 22222703
[TBL] [Abstract][Full Text] [Related]
11. Acetylcholine release by human colon cancer cells mediates autocrine stimulation of cell proliferation.
Cheng K; Samimi R; Xie G; Shant J; Drachenberg C; Wade M; Davis RJ; Nomikos G; Raufman JP
Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G591-7. PubMed ID: 18653726
[TBL] [Abstract][Full Text] [Related]
12. Overview of muscarinic receptor subtypes.
Eglen RM
Handb Exp Pharmacol; 2012; (208):3-28. PubMed ID: 22222692
[TBL] [Abstract][Full Text] [Related]
13. Effect of muscarinic receptor modulators in the hypothalamic supraoptic nucleus of the rat.
Mori M; Tsushima H; Kamiya T; Matsuda T
Jpn J Pharmacol; 1994 Dec; 66(4):413-9. PubMed ID: 7723216
[TBL] [Abstract][Full Text] [Related]
14. Muscarinic receptor agonists and antagonists: effects on cardiovascular function.
Harvey RD
Handb Exp Pharmacol; 2012; (208):299-316. PubMed ID: 22222704
[TBL] [Abstract][Full Text] [Related]
15. Selective M3 muscarinic receptor antagonist inhibits small-cell lung carcinoma growth in a mouse orthotopic xenograft model.
Ami N; Koga K; Fushiki H; Ueno Y; Ogino Y; Ohta H
J Pharmacol Sci; 2011; 116(1):81-8. PubMed ID: 21512307
[TBL] [Abstract][Full Text] [Related]
16. Muscarinic agonists and antagonists: effects on gastrointestinal function.
Ehlert FJ; Pak KJ; Griffin MT
Handb Exp Pharmacol; 2012; (208):343-74. PubMed ID: 22222706
[TBL] [Abstract][Full Text] [Related]
17. Muscarinic receptor pharmacology and circuitry for the modulation of cognition.
Bubser M; Byun N; Wood MR; Jones CK
Handb Exp Pharmacol; 2012; (208):121-66. PubMed ID: 22222698
[TBL] [Abstract][Full Text] [Related]
18. Acetylcholine stimulates cortical precursor cell proliferation in vitro via muscarinic receptor activation and MAP kinase phosphorylation.
Ma W; Maric D; Li BS; Hu Q; Andreadis JD; Grant GM; Liu QY; Shaffer KM; Chang YH; Zhang L; Pancrazio JJ; Pant HC; Stenger DA; Barker JL
Eur J Neurosci; 2000 Apr; 12(4):1227-40. PubMed ID: 10762352
[TBL] [Abstract][Full Text] [Related]
19. In primary neuronal cultures muscarinic m1 and m3 receptor mRNA levels are regulated by agonists, partial agonists and antagonists.
Brusa R; Gamalero SR; Genazzani E; Eva C
Eur J Pharmacol; 1995 Mar; 289(1):9-16. PubMed ID: 7781716
[TBL] [Abstract][Full Text] [Related]
20. Basic and clinical aspects of non-neuronal acetylcholine: expression of non-neuronal acetylcholine in lung cancer provides a new target for cancer therapy.
Song P; Spindel ER
J Pharmacol Sci; 2008 Feb; 106(2):180-5. PubMed ID: 18285655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
